Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2007
08/08/2007EP1324992B1 Cyclized benzamide neurokinin antagonists for use in therapy
08/08/2007EP1323712B1 Process for producing multiform crystal of donepezil hydrochloride
08/08/2007EP1277736B1 Novel bicyclic compounds
08/08/2007EP1071425B1 Treatment of depression and pharmaceutical preparations therefor
08/08/2007EP0882065B1 Novel human metabotropic glutamate receptor
08/08/2007EP0843516B1 Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits
08/08/2007EP0837129B1 Epimorphin antagonist and process for producing the same
08/08/2007CN1330654C Fused bicyclic pyrimidine derivatives
08/08/2007CN1330651C Fused heterocyclic compounds
08/08/2007CN1330649C Carbamate-substituted pyrazolopyridines
08/08/2007CN1330641C Activator for peroxisome proliferator-responsive receptor delta
08/08/2007CN1330637C Novel compounds of family of 3-alkyl-(4,5-diphenyl-imidazol-1-yl) and their use as soothing agents
08/08/2007CN1330357C Composite panaxadiol and saponin with physiologic activity and its use and preparation
08/08/2007CN1330352C Health care wine and preparation method
08/08/2007CN1330339C Medicine for treating encephalatrophy and preparation thereof
08/08/2007CN1330305C Highly flexible transdermal therapeutic system having nicotine as active substance
08/08/2007CN1330303C Use of genistein in the manufacture of a medicament for the treatment of osteoporosis and obesity, and compositions containing genistein in combination with vitamin d and k
08/08/2007CN1330296C Propolis soft capsule and its preparation method
08/08/2007CN1330295C Slow-releasing tablets of oral medicine and preparation thereof
08/08/2007CN1330293C Fleabane oral disintegration tablet and its preparing process
08/08/2007CN101014708A Use of antisense oligonucleotides or sirna to suppress expression of eif-5a1
08/08/2007CN101014600A 6-(2-alkyl-phenyl) - pyrido[2,3-d] pyrimidines useful as proteine kinase inhibitors
08/08/2007CN101014566A Pentafluorosulfanylphenyl-substituted benzoylguanidines, method for the production thereof, their use as a medicament or diagnostic agent, and a medicament containing these compounds
08/08/2007CN101014359A Method of treating parkinson's disease in humans by direct infusion of glial cell-line derived neurotrophic factor into the zona incerta
08/08/2007CN101014337A Method for treating nervous system disorders and conditions
08/08/2007CN101014325A Medicament for the treatment of central nervous system disorders
08/08/2007CN101012452A Formula constituted by cytokine and compound, its action of promoting nerve regeneration and action of researching and diagnosing nervous system disease
08/08/2007CN101012189A Crystalline forms and crystalline forms of optical enantiomers of modafinil and method for the procution same
08/08/2007CN101012159A Method of preparing alpha-asarone
08/08/2007CN101011576A Compositions and methods for treating or preventing inflammatory diseases
08/08/2007CN101011564A Medicine for treating pompholyx, herpes zoster and neurodermatitis and its preparing process
08/08/2007CN101011549A Medicament for nourishing liver and kidney, strengthening brain and developing intelligence and its preparation method
08/08/2007CN101011538A Hemiplegia rapid recovery capsule(pill) and preparation technique thereof
08/08/2007CN101011537A Zhuangyuanxing pill for treating insomnia, amnesia and improving intelligence
08/08/2007CN101011535A Pill for nourishing blood, reinforcing body fluid, nourishing blood and diapelling arthralgia and its preparation
08/08/2007CN101011521A Chinese patent drug for nourishing liver and kidney, tranquilizing the mind and developing intelegence and its preparation method
08/08/2007CN101011476A Traditional Chinese medicine composition for drug rehabilitation
08/08/2007CN101011473A Medicament for treating hands and feet caused by paralysis apoplexy
08/08/2007CN101011468A Yixinningshen tablet and its preparation method
08/08/2007CN101011466A Method for extraction of gelsemium alkaloids
08/08/2007CN101011455A Antialcoholism quick lozenge and preparation process thereof
08/08/2007CN101011450A Quality control method for lucid ganoderma gynostemma pentaphylla oral liquid
08/08/2007CN101011447A Functional foodstuff for dispelling residual poison in vivo after treatment of drug addicts and method for making same
08/08/2007CN101011437A Traditional Chinese medicine achyranthes extract and preparation method and use thereof
08/08/2007CN101011435A Shanxiangyuan leaf extract, preparation method and uses thereof
08/08/2007CN101011409A Collunarium containing vitamin B12
08/08/2007CN101011405A Pharmaceutical composition for treating ischemic cerebral vascular disease
08/08/2007CN101011391A Clonidine paster for treating children's hyperkinetic symptom, twitch symptom and its preparation method
08/08/2007CN101011207A Health care medicated pillow
08/08/2007CN101011161A Plant beverage formulation with anti-alcohol function and making method thereof
08/08/2007CN101011073A Ginko-wheat composite powder and its producing technology
08/07/2007USRE39762 e.g. 13-desmethoxy-18-hydroxyl-FK-520; compounds of the invention may be administered to achieve immunosuppression or to stimulate nerve growth and regeneration
08/07/2007US7253295 Chloride channel opener
08/07/2007US7253284 Chemical compounds
08/07/2007US7253281 2-(9-bromo-3,4,10,10a-tetrahydro-1H-pyrazino[1,2-a]indol-2-yl)-cyclobutanone; treating disorders of the central nervous system, damage to the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes insipidus, obesity and sleep apnea
08/07/2007US7253202 Substituted benzodioxepines
08/07/2007US7253201 Small molecule inhibitors of necrosis
08/07/2007US7253199 Azole derivatives and pharmaceutical compositions containing them
08/07/2007US7253198 Hydroxyethylamine derivatives for the treatment of Alzheimer's disease
08/07/2007US7253196 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
08/07/2007US7253194 Compounds and inhibitors of phospholipases
08/07/2007US7253191 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
08/07/2007US7253190 G protein-coupled receptors activators such as 2-[2-(3-chlorophenyl)-2H-tetrazol-5-yl]pyridine, used as analgesics, anxiolytic, antidepressants, and for prophylaxis of psychological disorders
08/07/2007US7253187 Heterocyclic inhibitors of ERK2 and uses thereof
08/07/2007US7253181 β3 adrenergic agonists
08/07/2007US7253179 pyrido[4,3-b]carbazol derivatives; melanin-concentrating hormone (MCH) and somatostatin receptors modulator; eating disorders; obesity; anxiolytic agents; psychological disorders
08/07/2007US7253174 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis.
08/07/2007US7253173 E.g., Methyl 3-[(4-[(diethylamino)carbonyl]phenyl)(4-benzyl-piperazin-1-yl)methyl]phenylcarbamate and Methyl 3-{(S)-{4-[(diethylamino)carbonyl]phenyl}[4-(1,3-thiazol-4-ylmethyl)piperazin-1-yl]methyl}phenylcarbamate
08/07/2007US7253172 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid
08/07/2007US7253171 Antiinflammatory agents; immunology diseases; multiple sclerosis; antihistamines; antidiabetic agents; vision defects; antiarthritic agents; skin disorders; antitumor agents
08/07/2007US7253169 Aza compounds, pharmaceutical compositions and methods of use
08/07/2007US7253166 6-phenyl-7H-pyrrolo[2,3-d]pyrimidine compounds that induce neuronal differentiation in embryonic stem cells
08/07/2007US7253163 Benzothiazine and benzothiadiazine compounds
08/07/2007US7253162 Alzheimer's disease; cognition activators; central nervous system disorders
08/07/2007US7253161 Cognition activators; neurodegenerative disease; anxiolytic agents; Alzheimer's diseas; Pick's disease; schizophrenia; psychological disorders; antiischemic agents; antiepileptic agents; antidepressants
08/07/2007US7253158 Sulfonamides
08/07/2007US7253155 Combination of a tetra-substituted pyrimidopyrimidine, and a corticosteroid simultaneously or within 14 days of each other
08/07/2007US7253153 Brain disorders; antiischemic agents; antiepileptic agents; cardiovascular disorders; vision defects; spinal cord injuries; psychological disorders; anxiolytic agents; schizophrenia
08/07/2007US7252934 Synergistic activation of regulatory elements by Rel proteins and a steroid receptor
08/07/2007US7252845 Synergistic compositions containing aromatic compounds and terpenoids present in Alpinia galanga
08/07/2007CA2381770C Human ctla-4 antibodies and their uses
08/07/2007CA2365832C Pharmacological screening of neuronally active substances
08/07/2007CA2325842C Methods for making and delivering rho-antagonist tissue adhesive formulations to the injured mammalian central and peripheral nervous systems and uses thereof
08/07/2007CA2301799C Novel conjugates of opioids and endogenous carriers
08/07/2007CA2270955C Pharmaceutical composition containing morphinan derivative for treating drug dependence
08/07/2007CA2247734C New piperazine and piperidine compounds selectively binding dopamine and serotonin receptors
08/07/2007CA2207804C Amides of mono and bicarboxylic acids with amino acids or glycosamines, selectively active on the cannabinoid peripheral receptor
08/07/2007CA2092718C Use of protective agents against reactive oxygen species
08/02/2007WO2007087425A1 Methods and compositions for treating schizophrenia
08/02/2007WO2007087154A2 Methods for enhancing therapeutic effects of a neurotoxin
08/02/2007WO2007087151A2 Combination of ache inhibitor and 5-ht6 antagonist for the treatment of cognitive dysfunction
08/02/2007WO2007087135A2 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
08/02/2007WO2007086948A1 Dnt-fumarate and methods of preparation thereof
08/02/2007WO2007086800A1 Novel heteroaryl substituted benzothiazoles
08/02/2007WO2007086799A1 Amide substituted quinolines
08/02/2007WO2007086587A1 Agent for targeting drug to cerebral neuron
08/02/2007WO2007086584A1 NOVEL INHIBITOR OF FabK AND FabI/K
08/02/2007WO2007086545A1 Method for screening cell function regulator
08/02/2007WO2007086493A1 Medicine for transnasal administration
08/02/2007WO2007086354A1 Novel histidine derivative